Skip to main content
Journal of Clinical Medicine logoLink to Journal of Clinical Medicine
. 2021 Nov 30;10(23):5662. doi: 10.3390/jcm10235662

Incidence and Mortality of Emergency Patients Transported by Emergency Medical Service Personnel during the Novel Corona Virus Pandemic in Osaka Prefecture, Japan: A Population-Based Study

Yusuke Katayama 1,*,, Kenta Tanaka 2, Tetsuhisa Kitamura 2,, Taro Takeuchi 2, Shota Nakao 3,, Masahiko Nitta 4,, Taku Iwami 5,, Satoshi Fujimi 6,, Toshifumi Uejima 7,, Yuuji Miyamoto 8,, Takehiko Baba 9,, Yasumitsu Mizobata 10,, Yasuyuki Kuwagata 11,, Takeshi Shimazu 1, Tetsuya Matsuoka 3,
Editor: Roland Bingisser
PMCID: PMC8658143  PMID: 34884363

Abstract

Although the COVID-19 pandemic affects the emergency medical service (EMS) system, little is known about the impact of the COVID-19 pandemic on the prognosis of emergency patients. This study aimed to reveal the impact of the COVID-19 pandemic on the EMS system and patient outcomes. We included patients transported by ambulance who were registered in a population-based registry of patients transported by ambulance. The endpoints of this study were the incident number of patients transported by ambulance each month and the number of deaths among these patients admitted to hospital each month. The incidence rate ratio (IRR) and 95% confidence interval (CI) using a Poisson regression model with the year 2019 as the reference were calculated. A total of 500,194 patients were transported in 2019, whereas 443,321 patients were transported in 2020, indicating a significant decrease in the number of emergency patients transported by ambulance (IRR: 0.89, 95% CI: 0.88–0.89). The number of deaths of emergency patients admitted to hospital was 11,931 in 2019 and remained unchanged at 11,963 in 2020 (IRR: 1.00, 95% CI: 0.98–1.03). The incidence of emergency patients transported by ambulance decreased during the COVID-19 pandemic in 2020, but the mortality of emergency patients admitted to hospital did not change in this study.

Keywords: COVID-19, emergency medical service, ambulances, incidence, mortality, epidemiology

1. Introduction

Outbreaks of infection by the novel corona virus (COVID-19), which was confirmed in Wuhan, China in December 2019, have spread not only in China but also around the world. In Japan, the number of patients with COVID-19 was about 740,000 on 31 May 2021 [1]. The characteristics of COVID-19 are that some of its symptoms, such as fever, cough, sore throat, and general malaise, are common with other upper respiratory tract infections, and some patients are asymptomatic [2]. However, 20% of COVID-19 patients are severely affected and admitted to hospital, and a lower but not negligible rate (3–4%) also need intensive management in the ICU, for their acute respiratory failure, by intubation and mechanical ventilation [3].

As the number of patients with COVID-19 increased, especially in Europe and the United States, the number of health care workers infected with COVID-19 also increased, placing aspects of the health care system, such as emergency medicine and intensive care, into a worldwide state of crisis [4]. The health care system in Japan is funded by public health insurance, and the emergency medical service (EMS) system, which handles all ambulance calls, is a free public service [5]. However, the impact of the COVID-19 pandemic on the EMS system has not been fully revealed, and little is known about the impact of the COVID-19 pandemic on the prognosis of emergency patients.

Osaka Prefecture is the largest metropolitan area in western Japan, with a population of 8.8 million. The annual number of ambulance calls is about 500,000 in this area and that of patients transported to hospital by ambulance is about 200,000 [6]. After the first patient in Osaka Prefecture was confirmed to have COVID-19 on 23 January 2020, the cumulative number of patients with COVID-19 in the prefecture rose to 1732 by 31 May 2020, which was considered the first surge of COVID-19 [7]. We previously revealed the characteristics and outcome of patients with COVID-19 in Osaka Prefecture [7]. Those patients in Osaka Prefecture suspected of having COVID-19 based on their medical and travel history were transferred to a hospital that specializes in the management of COVID-19 for PCR testing. When a COVID-19 outbreak was reported in places such as bars and live music venues, the staff in each public health centre in charge followed up on the people involved, and data on the individuals with positive PCR test results were collected to determine whether they were asymptomatic. All patients with positive PCR test results for COVID-19 were reported to the public health centres in accordance with the Infectious Disease Control Law [8]. In Osaka Prefecture, the first patient with COVID-19 was identified on 23 January 2020, and by 31 December 2020, 466,416 PCR tests had been conducted and the number of patients with COVID-19 was 29,999 [9]. In Japan, due to an increase in the number of patients with COVID-19, the Japanese government declared a state of emergency based on the law on 7 April 2020. At that time, we revealed the influence of the COVID-19 pandemic on the EMS system in Osaka City [10]. The goals of this investigation were to determine the impact of the COVID-19 pandemic on the incident number of emergency patients transported by ambulance (emergency patients) and the number of deaths of emergency patients admitted to hospital.

2. Materials and Methods

2.1. Study Design and Settings

This was a retrospective descriptive study with a study period from 1 January 2019 to 31 December 2020. All data about patients who were transported by ambulance from ambulance call to hospital discharge were entered into the ORION (Osaka Emergency Information Research Intelligent Operation Network) system. Information on the system configuration of ORION was previously described in detail [6,11]. ORION data are considered administrative records, and the ORION data are anonymized without specific personal data, such as patient name, date of birth, and address. Therefore, the requirement of obtaining patient informed consent was waived. This study was approved by the Ethics Committee of Osaka University Graduate School of Medicine (approval no. 15003).

2.2. Setting and Selection of Patients

In 2019, 8,823,452 people lived in the 1905 km2 area of Osaka Prefecture [12]. Of that population, 4,235,996 people (48.0%) were male and 2,382,016 people (27.0%) were elderly, aged 65 years old or more. We included patients transported by ambulance whose cleaned data were recorded in the ORION system. Therefore, we excluded patients who were not registered in the ORION system or who had missing data.

2.3. Outcomes

The primary endpoints of this study were the incident number of patients transported by ambulance in each month of the study period and the number of deaths of emergency patients admitted to hospital in each month. In this study, patients who died in the emergency department were excluded from the outcome.

2.4. Measurements

The ORION system checks for errors in the input in-hospital data, and the staff of each emergency hospital can correct them, if necessary. Through these tasks, cell phone app data, ambulance records, and the in-hospital data such as diagnosis and prognosis can be comprehensively registered for each patient transported by an ambulance. The registered data are cleaned by the Working Group to analyse the emergency medical care system in Osaka Prefecture. Among the collected and cleaned data, we excluded inconsistent data that did not contain all of the cell phone app data, ambulance records, and in-hospital data such as diagnosis and prognosis. In addition, we also excluded patients whose sex as registered by the fire department did not match that registered by the hospital or whose sex identifier was missing. We also excluded patients whose age input by the fire department and that by the hospital differed by 3 years or more. When this difference was present, we defined the age input by the hospital as the patient’s true age [5].

2.5. Data Analysis

First, we calculated the number of patients transported by ambulance by reason for ambulance call on a monthly basis from January to December 2020. As a control, we calculated the same data on a monthly basis from January to December 2020. Reason for ambulance call was divided into ‘fire accident’, ‘natural disaster’, ‘water accident’, ‘traffic accident involving car, ship, or aircraft’, ‘injury, poisoning, and disease due to industrial accident’, ‘disease and injury due to sports’, ‘other injury’, ‘trauma due to assault’, ‘acute disease’, ‘interhospital transport’, and ‘others’ [6,11]. To evaluate the impact of the COVID-19 pandemic on the EMS system, we calculated the incidence rate of the number of emergency patients. We also calculated the incidence rate ratio (IRR) and its 95% confidence interval (CI) using a Poisson regression model with the year 2019 as control year. We categorized the patients by age group (children (0–19 years old), adult (20–64 years old), and elderly (65 years old and over)) and also calculated their respective IRR and 95% CI values. Next, we calculated the number of deaths of emergency patients admitted to hospital by reason for ambulance call in each month and similarly calculated the IRR and its 95% CI values. The offset for calculating the IRR was set to the population of Osaka Prefecture in 2019 (8,823,452 people) [12]. The death of emergency patients admitted to hospital was defined from the outcome at 21 days after hospital admission. In addition, in a subgroup analysis, we selected the patients transported by ambulance whose reason for ambulance call was ‘acute disease’ and similarly calculated the IRR and 95% CI values. Statistical analyses were performed using STATA version 16.0 MP software (StataCorp LP, College Station, TX, USA). This manuscript was written based on the STROBE statement to assess the reporting of cohort and cross-sectional studies [13]. All methods in this study have been carried out in accordance with the declaration of Helsinki.

3. Results

The total number of patients registered in ORION was 512,054 in 2019, of which 500,194 (97.7%) were eligible for analysis after excluding cases with missing data. In addition, the total number of patients registered in ORION was 451,524 in 2020, of which 443,321 (98.2%) were eligible for analysis after excluding cases with missing data. Among the 443,321 patients registered in the ORION registry from January to December 2020, 193,060 patients were hospitalized, and 11,963 patients were dead at 21 days after hospital admission. In contrast, among the 500,194 patients registered in the ORION system from January to December 2019, 203,889 patients were hospitalized, and 11,931 patients were dead at 21 days after hospital admission.

3.1. Incidence Analyses by Reason of Ambulance Call

Table 1 shows the number of emergency patients and the IRR (95% CI) in each month by the reason for ambulance call during the study period. The number of emergency patients from January to December 2020 (n = 443,321) was significantly decreased from that transported from January to December 2019 (n = 500,194) (IRR: 0.89, 95% CI: 0.88–0.89). The most common reason for an ambulance call was ‘acute disease’ for 340,655 patients in 2019 and 300,502 patients in 2020. During the study period, the reasons for an ambulance call for which the number of emergency patients decreased were ‘traffic accident involving car, ship, or aircraft’ (IRR: 0.86, 95% CI: 0.85–0.87), ‘injury, poisoning, and disease due to industrial accident’ (IRR: 0.82, 95% CI: 0.79–0.86), ‘disease and injury due to sport’ (IRR: 0.57, 95% CI: 0.53–0.60), ‘other injury’ (IRR: 0.92, 95% CI: 0.91–0.93), ‘trauma due to assault’ (IRR: 0.88, 95% CI: 0.84–0.93), ‘acute disease’ (IRR: 0.88, 95% CI: 0.88–0.89), and ‘interhospital transport’ (IRR: 0.90, 95% CI: 0.89–0.91). By month, the greatest decrease in the number of emergency patients was in April (IRR: 0.78, 95% CI: 0.76–0.79), followed by May (IRR: 0.79, 95% CI: 0.78–0.80).

Table 1.

The number of emergency patients registered in the Osaka Emergency Information Research Intelligent Operation Network system.

January February March April May June July August September October November December Total
Acute disease 2019 34,239 25,757 26,544 26,370 27,524 27,131 29,555 32,882 27,935 26,681 26,538 29,499 340,655
2020 30,857 25,663 24,224 21,363 21,760 23,247 25,619 30,656 24,781 24,418 23,563 24,351 300,502
IRR (95% CI) 0.90 (0.89–0.92) 1.00 (0.98–1.01) 0.91 (0.90–0.93) 0.81 (0.80–0.82) 0.79 (0.78–0.80) 0.86 (0.84–0.87) 0.87 (0.85–0.88) 0.93 (0.92–0.95) 0.89 (0.87–0.90) 0.92 (0.90–0.93) 0.89 (0.87–0.90) 0.83 (0.81–0.84) 0.88 (0.88–0.89)
p-value 0.00 0.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Disease and injury due to sport 2019 135 166 232 232 252 281 289 295 309 227 213 194 2825
2020 141 144 51 23 17 76 146 282 225 192 194 113 1604
IRR (95% CI) 1.04 (0.82–1.33) 0.87 (0.69–1.09) 0.22 (0.16–0.30) 0.10 (0.06–0.15) 0.07 (0.04–0.11) 0.27 (0.21–0.35) 0.51 (0.41–0.62) 0.96 (0.81–1.13) 0.73 (0.61–0.87) 0.85 (0.69–1.03) 0.91 (0.75–1.11) 0.58 (0.46–0.74) 0.57 (0.53–0.60)
p-value 0.72 0.21 0.00 0.00 0.00 0.00 0.00 0.59 0.00 0.09 0.35 0.00 0.00
Fire accident 2019 58 37 40 34 33 21 38 26 35 29 25 36 412
2020 52 37 28 22 29 18 24 31 12 26 26 48 353
IRR (95% CI) 0.90 (0.60–1.33) 1.00 (0.62–1.62) 0.70 (0.42–1.16) 0.65 (0.36–1.14) 0.88 (0.51–1.49) 0.86 (0.43–1.69) 0.63 (0.36–1.08) 1.19 (0.69–2.09) 0.34 (0.16–0.68) 0.90 (0.51–1.58) 1.04 (0.58–1.88) 1.33 (0.85–2.11) 0.86 (0.74–0.99)
p-value 0.57 1.00 0.15 0.11 0.61 0.64 0.08 0.51 0.00 0.69 0.89 0.19 0.03
Injury, poisoning, and disease due to industrial accident 2019 348 321 370 365 374 385 497 542 455 406 370 365 4798
2020 279 317 274 282 253 349 344 504 342 368 316 305 3933
IRR (95% CI) 0.80 (0.68–0.94) 0.99 (0.84–1.16) 0.74 (0.63–0.87) 0.77 (0.66–0.90) 0.68 (0.57–0.80) 0.91 (0.78–1.05) 0.69 (0.60–0.80) 0.93 (0.82–1.05) 0.75 (0.65–0.87) 0.91 (0.78–1.05) 0.85 (0.73–1.00) 0.84 (0.72–0.98) 0.82 (0.79–0.86)
p-value 0.01 0.87 0.00 0.00 0.00 0.18 0.00 0.24 0.00 0.17 0.04 0.02 0.00
Interhospital transport 2019 2897 2445 2626 2732 2553 2492 2662 2560 2493 2581 2601 2855 31,497
2020 2895 2451 2367 1924 1959 1996 2395 2424 2282 2493 2533 2615 28,334
IRR (95% CI) 1.00 (0.95–1.05) 1.00 (0.95–1.06) 0.90 (0.85–0.95) 0.70 (0.66–0.75) 0.77 (0.72–0.81) 0.80 (0.75–0.85) 0.90 (0.85–0.95) 0.95 (0.90–1.00) 0.92 (0.86–0.97) 0.97 (0.91–1.02) 0.97 (0.92–1.03) 0.92 (0.87–0.97) 0.90 (0.89–0.91)
p-value 0.98 0.93 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.22 0.34 0.00 0.00
Natural disaster 2019 0 0 0 0 0 3 2 1 0 4 0 0 10
2020 8 0 0 0 0 1 2 0 0 2 0 0 13
IRR (95% CI) NA NA NA NA NA 0.33 (0.01–4.15) 1.00 (0.07–13.80) NA NA 0.50 (0.05–3.49) NA NA 1.30 (0.53–3.31)
p-value 0.38 1.00 0.45 0.54
Other injury 2019 7116 5753 6317 6400 6157 5891 6312 6518 6253 6800 6785 7516 77,818
2020 6936 6151 5925 5021 5237 5536 6037 5837 5752 6645 6133 6552 71,762
IRR (95% CI) 0.97 (0.94–1.01) 1.07 (1.03–1.11) 0.94 (0.91–0.97) 0.78 (0.76–0.81) 0.85 (0.82–0.88) 0.94 (0.91–0.98) 0.96 (0.92–0.99) 0.90 (0.86–0.93) 0.92 (0.89–0.95) 0.98 (0.94–1.01) 0.90 (0.87–0.94) 0.87 (0.84–0.90) 0.92 (0.91–0.93)
p-value 0.13 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.18 0.00 0.00 0.00
Self-induced injury 2019 197 195 245 216 254 291 286 270 254 258 240 247 2953
2020 265 217 250 184 253 270 315 267 316 297 204 229 3067
IRR (95% CI) 1.35 (1.11–1.63) 1.11 (0.91–1.36) 1.02 (0.85–1.22) 0.85 (0.70–1.04) 1.00 (0.83–1.19) 0.93 (0.78–1.10) 1.10 (0.94–1.30) 0.99 (0.83–1.18) 1.24 (1.05–1.47) 1.15 (0.97–1.37) 0.85 (0.70–1.03) 0.93 (0.77–1.11) 1.04 (0.99–1.09)
p-value 0.00 0.28 0.82 0.11 0.96 0.38 0.24 0.90 0.01 0.10 0.09 0.41 0.14
Traffic accident involving car, ship, or aircraft 2019 2620 2510 2997 3248 3024 2878 3198 3068 3067 3207 3223 3159 36,199
2020 2635 2578 2679 1891 2127 2658 2843 2695 2678 2820 2712 2818 31,134
IRR (95% CI) 1.01 (0.95–1.06) 1.03 (0.97–1.09) 0.89 (0.85–0.94) 0.58 (0.55–0.62) 0.70 (0.67–0.74) 0.92 (0.88–0.97) 0.89 (0.84–0.94) 0.88 (0.83–0.93) 0.87 (0.83–0.92) 0.88 (0.84–0.93) 0.84 (0.80–0.89) 0.89 (0.85–0.94) 0.86 (0.85–0.87)
p-value 0.84 0.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Trauma due to assault 2019 268 207 232 232 224 228 226 256 225 217 229 252 2796
2020 250 225 229 171 197 210 218 185 197 202 185 205 2474
IRR (95% CI) 0.93 (0.78–1.11) 1.09 (0.90–1.32) 0.99 (0.82–1.19) 0.74 (0.60–0.90) 0.88 (0.72–1.07) 0.92 (0.76–1.12) 0.96 (0.80–1.17) 0.72 (0.59–0.88) 0.88 (0.72–1.06) 0.93 (0.76–1.13) 0.81 (0.66–0.98) 0.81 (0.67–0.98) 0.88 (0.84–0.93)
p-value 0.43 0.39 0.89 0.00 0.19 0.39 0.70 0.00 0.17 0.46 0.03 0.03 0.00
Water accident 2019 5 3 6 2 2 2 7 9 9 3 1 3 52
2020 3 4 2 6 3 5 4 2 4 5 2 3 43
IRR (95% CI) 0.60 (0.09–3.08) 1.33 (0.23–9.10) 0.33 (0.03–1.86) 3.00 (0.54–30.39) 1.50 (0.17–17.96) 2.50 (0.41–26.25) 0.57 (0.12–2.25) 0.22 (0.02–1.07) 0.44 (0.10–1.59) 1.67 (0.32–10.73) 2.00 (0.10–117.99) 1.00 (0.13–7.47) 0.83 (0.54–1.26)
p-value 0.51 0.73 0.18 0.18 0.69 0.29 0.39 0.04 0.18 0.51 0.63 1.00 0.36
Other 2019 14 9 13 11 13 12 11 7 11 7 11 60 179
2020 9 6 9 11 9 5 8 15 4 11 5 10 102
IRR (95% CI) 0.64 (0.25–1.59) 0.67 (0.20–2.10) 0.69 (0.26–1.75) 1.00 (0.39–2.54) 0.69 (0.26–1.75) 0.42 (0.11–1.27) 0.73 (0.25–1.99) 2.14 (0.82–6.21) 0.36 (0.08–1.23) 1.57 (0.56–4.78) 0.45 (0.12–1.42) 0.17 (0.08–0.33) 0.57 (0.44–0.73)
p-value 0.31 0.45 0.40 1.00 0.40 0.10 0.50 0.09 0.08 0.36 0.14 0.00 0.00

IRR: incident rate ratio; CI: confidence interval; NA: no assessment. IRR is for 2020 versus 2019.

Table 2 shows the number of emergency patients and the IRR (95% CI) in each month by the age groups during the study period. In the subgroup analysis by age group, the number of emergency patients decreased among children during the study period (IRR: 0.68, 95% CI: 0.67–0.69). However, for adults and the elderly, the number of emergency patients decreased after March 2020 compared to that in 2019.

Table 2.

The number of emergency patients registered in the Osaka Emergency Information Research Intelligent Operation Network system.

January February March April May June July August September October November December Total
Total 2019 47,897 37,403 39,622 39,842 40,410 39,615 43,083 46,434 41,046 40,420 40,236 44,186 500,194
2020 44,330 37,793 36,038 30,898 31,844 34,371 37,955 42,898 36,593 37,479 35,873 37,249 443,321
IRR (95% CI) 0.93 (0.91–0.94) 1.01 (1.00–1.03) 0.91 (0.90–0.92) 0.78 (0.76–0.79) 0.79 (0.78–0.80) 0.87 (0.86–0.88) 0.88 (0.87–0.89) 0.92 (0.91–0.94) 0.89 (0.88–0.90) 0.93 (0.91–0.94) 0.89 (0.88–0.90) 0.84 (0.83–0.85) 0.89 (0.88–0.89)
p-value 0.00 0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Children 2019 5108 3603 3937 4406 4565 4817 4833 4516 4269 3883 3699 4429 52,065
2020 4199 3215 2766 2267 2293 2686 3186 3286 2949 3081 2945 2661 35,534
IRR (95% CI) 0.82 (0.79–0.86) 0.89 (0.85–0.94) 0.70 (0.67–0.74) 0.51 (0.49–0.54) 0.50 (0.48–0.53) 0.56 (0.53–0.58) 0.66 (0.63–0.69) 0.73 (0.70–0.76) 0.69 (0.66–0.72) 0.79 (0.76–0.83) 0.80 (0.76–0.84) 0.60 (0.57–0.63) 0.68 (0.67–0.69)
p-value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Adults 2019 13,925 11,519 12,824 12,782 13,116 13,142 14,689 16,034 13,762 13,364 12,478 13,890 161,525
2020 13,441 11,635 11,647 10,034 10,534 11,623 13,243 14,640 11,948 11,891 10,890 10,683 142,209
IRR (95% CI) 0.97 (0.94–0.99) 1.01 (0.98–1.04) 0.91 (0.89–0.93) 0.79 (0.76–0.81) 0.80 (0.78–0.82) 0.88 (0.86–0.91) 0.90 (0.88–0.92) 0.91 (0.89–0.93) 0.87 (0.85–0.89) 0.89 (0.87–0.91) 0.87 (0.85–0.90) 0.77 (0.75–0.79) 0.88 (0.87–0.89)
p-value 0.00 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Elderlies 2019 28,864 22,281 22,861 22,654 22,729 21,656 23,561 25,884 23,015 23,173 24,059 25,867 286,604
2020 26,690 22,943 21,625 18,597 19,017 20,062 21,526 24,972 21,696 22,507 22,038 23,905 265,578
IRR (95% CI) 0.92 (0.91–0.94) 1.03 (1.01–1.05) 0.95 (0.93–0.96) 0.82 (0.81–0.84) 0.84 (0.82–0.85) 0.93 (0.91–0.94) 0.91 (0.90–0.93) 0.96 (0.95–0.98) 0.94 (0.93–0.96) 0.97 (0.95–0.99) 0.92 (0.90–0.93) 0.92 (0.91–0.94) 0.93 (0.92–0.93)
p-value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

IRR: incident rate ratio; CI: confidence interval; NA: no assessment. IRR is for 2020 versus 2019.

3.2. Mortality Analyses by Reason of Ambulance Call

Table 3 shows the number of deaths of emergency patients admitted to hospital and the IRR (95% CI) in each month by the reason for ambulance call. The number of deaths of emergency patients admitted to hospital was 11,931 in 2019 and remained essentially unchanged at 11,963 in 2020 (IRR: 1.00, 95% CI: 0.98–1.03). There was no statistically significant change in the number of deaths of emergency patients admitted to hospital for each reason for an ambulance call between 2019 and 2020, and no statistically significant differences were identified between 2019 and 2020 for each month.

Table 3.

The number of deaths among hospitalized emergency patients registered in the Osaka Emergency Information Research Intelligent Operation Network system.

Reason for Ambulance Call January February March April May June July August September October November December Total
Acute disease 2019 1112 829 870 770 767 670 715 698 755 791 908 942 9827
2020 1028 913 882 756 748 695 718 723 706 800 873 1014 9856
IRR (95% CI) 0.92 (0.85–1.01) 1.10 (1.00–1.21) 1.01 (0.92–1.11) 0.98 (0.89–1.09) 0.98 (0.88–1.08) 1.04 (0.93–1.16) 1.00 (0.90–1.12) 1.04 (0.93–1.15) 0.94 (0.84–1.04) 1.01 (0.92–1.12) 0.96 (0.88–1.06) 1.08 (0.98–1.18) 1.00 (0.98–1.03)
p-value 0.07 0.04 0.77 0.72 0.63 0.50 0.94 0.51 0.20 0.82 0.41 0.10 0.84
Disease and injury due to sport 2019 0 1 0 0 0 0 0 0 0 0 0 0 1
2020 0 0 0 0 0 0 0 0 0 0 0 0 0
IRR (95% CI) NA NA NA NA NA NA NA NA NA NA NA NA NA
p-value
Fire accident 2019 3 1 0 2 2 0 5 0 2 3 1 0 19
2020 3 2 1 0 1 0 1 0 0 1 0 0 9
IRR (95% CI) 1.00 (0.13–7.47) 2.00 (0.10–117.99) NA NA 0.50 (0.01–9.60) NA 0.20 (0.00–1.79) NA NA 0.33 (0.01–4.15) NA NA 0.47 (0.19–1.10)
p-value 1.00 0.63 0.63 0.13 0.38 0.06
Injury, poisoning, and disease due to industrial accident 2019 2 0 1 0 3 2 3 2 1 2 1 2 19
2020 3 1 0 4 0 2 1 0 2 3 0 0 16
IRR (95% CI) 1.50 (0.17–17.96) NA NA NA NA 1.00 (0.07–13.80) 0.33 (0.01–4.15) NA 2.00 (0.10–117.99) 1.50 (0.17–17.96) NA NA 0.84 (0.41–1.73)
p-value 0.69 1.00 0.38 0.63 0.69 0.62
Interhospital transport 2019 119 117 86 110 98 76 105 91 86 101 106 120 1215
2020 138 92 104 100 93 80 87 124 100 114 120 148 1300
IRR (95% CI) 1.16 (0.90–1.49) 0.79 (0.59–1.04) 1.21 (0.90–1.63) 0.91 (0.69–1.20) 0.95 (0.71–1.27) 1.05 (0.76–1.46) 0.83 (0.62–1.11) 1.36 (1.03–1.81) 1.16 (0.86–1.57) 1.13 (0.86–1.49) 1.13 (0.86–1.48) 1.23 (0.96–1.58) 1.07 (0.99–1.16)
p-value 0.24 0.08 0.19 0.49 0.72 0.75 0.19 0.02 0.31 0.38 0.35 0.09 0.09
Natural disaster 2019 0 0 0 0 0 0 0 0 0 0 0 0 0
2020 0 0 0 0 0 0 0 0 0 0 0 0 0
IRR (95% CI) NA NA NA NA NA NA NA NA NA NA NA NA NA
p-value
Other injury 2019 73 57 33 50 36 39 47 35 30 53 58 72 583
2020 62 42 47 37 36 44 42 43 41 39 44 56 533
IRR (95% CI) 0.85 (0.60–1.21) 0.74 (0.48–1.12) 1.42 (0.89–2.29) 0.74 (0.47–1.15) 1.00 (0.61–1.63) 1.13 (0.72–1.78) 0.89 (0.58–1.38) 1.23 (0.77–1.98) 1.37 (0.83–2.27) 0.74 (0.47–1.13) 0.76 (0.50–1.14) 0.78 (0.54–1.12) 0.91 (0.81–1.03)
p-value 0.35 0.13 0.12 0.17 1.00 0.59 0.60 0.37 0.19 0.15 0.17 0.16 0.13
Self-induced injury 2019 8 6 7 15 13 12 11 10 5 17 12 11 127
2020 8 10 11 8 11 9 19 15 13 14 15 11 144
IRR (95% CI) 1.00 (0.33–3.06) 1.67 (0.55–5.58) 1.57 (0.56–4.78) 0.53 (0.20–1.34) 0.85 (0.34–2.05) 0.75 (0.28–1.94) 1.73 (0.78–4.02) 1.50 (0.63–3.73) 2.60 (0.87–9.31) 0.82 (0.38–1.78) 1.25 (0.55–2.92) 1.00 (0.39–2.54) 1.13 (0.89–1.45)
p-value 1.00 0.33 0.36 0.15 0.69 0.52 0.15 0.33 0.06 0.60 0.57 1.00 0.30
Traffic accident involving car, ship, or aircraft 2019 8 7 9 11 7 7 14 10 10 14 10 15 122
2020 9 8 13 6 7 7 1 10 9 7 9 8 94
IRR (95% CI) 1.13 (0.39–3.35) 1.14 (0.36–3.70) 1.44 (0.57–3.83) 0.55 (0.17–1.61) 1.00 (0.30–3.34) 1.00 (0.30–3.34) 0.07 (0.00–0.47) 1.00 (0.37–2.68) 0.90 (0.32–2.46) 0.50 (0.17–1.32) 0.90 (0.32–2.46) 0.53 (0.20–1.34) 0.77 (0.58–1.02)
p-value 0.81 0.80 0.40 0.24 1.00 1.00 0.00 1.00 0.82 0.13 0.82 0.15 0.06
Trauma due to assault 2019 0 0 0 2 0 1 0 1 0 1 0 0 5
2020 0 1 0 0 0 1 1 0 0 1 0 0 4
IRR (95% CI) NA NA NA NA NA 1.00 (0.01–78.50) NA NA NA 1.00 (0.01–78.50) NA NA 0.80 (0.16–3.72)
p-value 1.00 1.00 0.75
Water accident 2019 0 0 0 0 1 1 0 0 1 2 0 0 5
2020 0 0 0 1 0 0 0 0 1 0 0 0 2
IRR (95% CI) NA NA NA NA NA NA NA NA 1.00 (0.01–78.50) NA NA NA 0.40 (0.04–2.44)
p-value 1.00 0.29
Other 2019 0 0 0 1 0 0 1 0 0 0 0 6 8
2020 0 1 0 0 2 1 0 0 0 0 1 0 5
IRR (95% CI) NA NA NA NA NA NA NA NA NA NA NA NA 0.63 (0.16–2.17)
p-value 0.42

IRR: incident rate ratio; CI: confidence interval; NA: no assessment. IRR is for 2020 versus 2019.

Table 4 shows the number of deaths of emergency patients admitted to hospital and the IRR (95% CI) in each month by age groups. In subgroup analysis by age group, there was no increase of the number of deaths of emergency patients admitted to hospital among children (IRR: 0.81, 95% CI: 0.54–1.21), adults (IRR: 0.98, 95% CI: 0.91–1.05), and the elderly (IRR: 1.01, 95% CI: 0.98–1.04).

Table 4.

The number of deaths among hospitalized emergency patients registered in the Osaka Emergency Information Research Intelligent Operation Network system.

January February March April May June July August September October November December Total
Total 2019 1325 1018 1006 961 927 808 901 847 890 984 1096 1168 11,931
2020 1251 1070 1058 912 898 839 870 915 872 979 1062 1237 11,963
IRR (95% CI) 0.94 (0.87–1.02) 1.05 (0.96–1.15) 1.05 (0.96–1.15) 0.95 (0.87–1.04) 0.97 (0.88–1.06) 1.04 (0.94–1.15) 0.97 (0.88–1.06) 1.08 (0.98–1.19) 0.98 (0.89–1.08) 0.99 (0.91–1.09) 0.97 (0.89–1.06) 1.06 (0.98–1.15) 1.00 (0.98–1.03)
p-value 0.14 0.26 0.25 0.26 0.50 0.45 0.46 0.11 0.67 0.91 0.46 0.16 0.84
Children 2019 9 2 4 7 3 5 8 5 5 4 3 3 58
2020 5 8 4 3 1 2 3 2 3 4 2 10 47
IRR (95% CI) 0.56 (0.15–1.85) 4.00 (0.80–38.67) 1.00 (0.19–5.37) 0.43 (0.07–1.88) 0.33 (0.01–4.15) 0.40 (0.04–2.44) 0.38 (0.06–1.56) 0.40 (0.04–2.44) 0.60 (0.09–3.08) 1.00 (0.19–5.37) 0.67 (0.06–5.82) 3.33 (0.86–18.85) 0.81 (0.54–1.21)
p-value 0.30 0.07 1.00 0.23 0.38 0.29 0.15 0.29 0.51 1.00 0.69 0.06 0.29
Adults 2019 173 115 123 122 110 105 119 108 107 146 149 165 1542
2020 156 113 115 126 94 112 139 132 110 136 133 144 1510
IRR (95% CI) 0.90 (0.72–1.13) 0.98 (0.75–1.29) 0.93 (0.72–1.22) 1.03 (0.80–1.34) 0.85 (0.64–1.14) 1.07 (0.81–1.41) 1.17 (0.91–1.50) 1.22 (0.94–1.59) 1.03 (0.78–1.35) 0.93 (0.73–1.18) 0.89 (0.70–1.14) 0.87 (0.69–1.10) 0.98 (0.91–1.05)
p-value 0.35 0.89 0.60 0.80 0.26 0.64 0.21 0.12 0.84 0.55 0.34 0.23 0.56
Elderlies 2019 1143 901 879 832 814 698 774 734 778 834 944 1000 10,331
2020 1090 949 939 783 803 725 728 781 759 839 927 1083 10,406
IRR (95% CI) 0.95 (0.88–1.04) 1.05 (0.96–1.16) 1.07 (0.97–1.17) 0.94 (0.85–1.04) 0.99 (0.89–1.09) 1.04 (0.93–1.15) 0.94 (0.85–1.04) 1.06 (0.96–1.18) 0.98 (0.88–1.08) 1.01 (0.91–1.11) 0.98 (0.90–1.08) 1.08 (0.99–1.18) 1.01 (0.98–1.04)
p-value 0.26 0.26 0.16 0.22 0.78 0.47 0.24 0.23 0.63 0.90 0.69 0.07 0.60

IRR: incident rate ratio; CI: confidence interval; NA: no assessment. IRR is for 2020 versus 2019.

3.3. Subgroup Analyses by Age Groups among Patients with Acute Disease

Table 5 shows the number of emergency patients due to acute disease by age group and the IRR (95% CI) for each month during the study period. The number of paediatric patients transported by ambulance during the study period significantly decreased (30,961 patients in 2019 vs. 18,929 patients in 2020; IRR: 0.61, 95% CI: 0.60–0.62). The number of adult patients transported by ambulance also significantly decreased (107,634 patients in 2019 vs. 95,355 patients in 2020; IRR: 0.89, 95% CI: 0.88–0.89), as did that of the elderly patients transported by ambulance (202,620 patients in 2019 vs. 186,218 patients in 2020; IRR: 0.92, 95% CI: 0.92–0.93).

Table 5.

The number of emergency patients for acute disease registered in the Osaka Emergency Information Research Intelligent Operation Network system.

Acute Disease January February March April May June July August September October November December Total
Children 2019 3629 2273 2219 2451 2592 2924 2892 2776 2395 2089 1948 2773 30,961
2020 2837 1971 1500 1161 1027 1321 1662 1816 1426 1463 1411 1334 18,929
IRR (95% CI) 0.78 (0.74–0.82) 0.87 (0.82–0.92) 0.68 (0.63–0.72) 0.47 (0.44–0.51) 0.40 (0.37–0.43) 0.45 (0.42–0.48) 0.57 (0.54–0.61) 0.65 (0.62–0.69) 0.60 (0.56–0.64) 0.70 (0.65–0.75) 0.72 (0.68–0.78) 0.48 (0.45–0.51) 0.61 (0.60–0.62)
Adults 2019 9748 7644 8368 8266 8718 8792 9898 11,180 9155 8649 8083 9133 107,634
2020 9235 7669 7633 7025 7233 7781 8917 10,421 7999 7586 7088 6768 95,355
IRR (95% CI) 0.95 (0.92–0.97) 1.00 (0.97–1.04) 0.91 (0.88–0.94) 0.85 (0.82–0.88) 0.83 (0.80–0.86) 0.89 (0.86–0.91) 0.90 (0.88–0.93) 0.93 (0.91–0.96) 0.87 (0.85–0.90) 0.88 (0.85–0.90) 0.88 (0.85–0.91) 0.74 (0.72–0.76) 0.89 (0.88–0.89)
Elderlies 2019 20,862 15,840 15,957 15,653 16,214 15,415 16,765 18,926 16,385 15,943 16,507 17,593 202,060
2020 18,785 16,023 15,091 13,177 13,500 14,145 15,040 18,419 15,356 15,369 15,064 16,249 186,218
IRR (95% CI) 0.90 (0.88–0.92) 1.01 (0.99–1.03) 0.95 (0.92–0.97) 0.84 (0.82–0.86) 0.83 (0.81–0.85) 0.92 (0.90–0.94) 0.90 (0.88–0.92) 0.97 (0.95–0.99) 0.94 (0.92–0.96) 0.96 (0.94–0.99) 0.91 (0.89–0.93) 0.92 (0.90–0.94) 0.92 (0.92–0.93)

IRR: incident rate ratio; CI: confidence interval; NA: not assessment.

Table 6 shows the number of deaths of emergency patients admitted to hospital due to acute disease by age group and IRR (95% CI) for each month. The number of deaths among emergency paediatric patients admitted to hospital due to acute disease was 26 in 2019 and 25 in 2020 (IRR: 0.96, 95% CI: 0.53–1.73). The number of deaths among emergency adult patients admitted to hospital due to acute disease was 1210 in 2019 and 1171 in 2020 (IRR: 0.97, 95% CI: 0.89–1.05), and that among emergency elderly patients admitted to hospital due to acute disease was 8591 in 2019 and 8660 in 2020 (IRR: 1.01, 95% CI: 0.98–1.04). No statistically significant differences were identified between 2019 and 2020 for each month or by age group.

Table 6.

The number of deaths among hospitalized emergency patients for acute disease registered in the Osaka Emergency Information Research Intelligent Operation Network system.

Reason for Ambulance Call January February March April May June July August September October November December Total
Children 2019 4 2 1 2 2 3 3 2 3 2 0 2 26
2020 4 2 2 2 1 2 2 1 1 1 0 7 25
IRR (95% CI) 1.00 (0.19–5.37) 1.00 (0.07–13.80) 2.00 (0.10–117.99) 1.00 (0.07–13.80) 0.50 (0.01–9.60) 0.67 (0.06–5.82) 0.67 (0.06–5.82) 0.50 (0.01–9.60) 0.33 (0.01–4.15) 0.50 (0.01–9.60) NA 3.50 (0.67–34.53) 0.96 (0.53–1.73)
Adults 2019 143 84 107 96 79 88 88 81 92 106 117 129 1210
2020 124 90 88 95 75 90 108 100 84 95 106 116 1171
IRR (95% CI) 0.87 (0.68–1.11) 1.07 (0.79–1.46) 0.82 (0.61–1.10) 0.99 (0.74–1.33) 0.95 (0.68–1.32) 1.02 (0.75–1.39) 1.23 (0.92–1.65) 1.23 (0.91–1.68) 0.91 (0.67–1.24) 0.90 (0.67–1.19) 0.91 (0.69–1.19) 0.90 (0.69–1.16) 0.97 (0.89–1.05)
Elderlies 2019 965 743 762 672 686 579 624 615 660 683 791 811 8591
2020 900 821 792 659 672 603 608 622 621 704 767 891 8660
IRR (95% CI) 0.93 (0.85–1.02) 1.10 (1.00–1.22) 1.04 (0.94–1.15) 0.98 (0.88–1.09) 0.98 (0.88–1.09) 1.04 (0.93–1.17) 0.97 (0.87–1.09) 1.01 (0.90–1.13) 0.94 (0.84–1.05) 1.03 (0.93–1.15) 0.97 (0.88–1.07) 1.10 (1.00–1.21) 1.01 (0.98–1.04)

IRR: incident rate ratio; CI: confidence interval; NA: not assessment.

4. Discussion

In this study, we used data from a large population-based patient registry to determine the number of emergency patients and the number of deaths among these patients admitted to hospital in the COVID-19 pandemic during 2020 in Osaka Prefecture. Although the number of emergency patients decreased in 2020 compared with 2019, the number of deaths among the emergency patients admitted to hospital in 2020 was similar to that in 2019. The results of this study, which used population-based data to reveal the impact of an emerging infectious disease pandemic on the EMS system, could be useful to plan health care systems and policies.

The number of emergency patients decreased in 2020 compared with 2019, especially in April, May, and December. As well, the number of emergency patients due to acute disease as the reason for the ambulance call also decreased, especially in April, May, and December. A previous study in Venice, northern Italy, comparing the number of ambulance dispatches in 2019 and 2020, found that the COVID-19 pandemic reduced the number of ambulance dispatches in 2020 [14]. It was also reported that the number of emergency department visits decreased during the severe acute respiratory syndrome (SARS) pandemic that spread in 2003 [15,16,17,18,19]. Thus, when an infectious disease spreads throughout a city or society, the number of emergency department visits may decrease as a result of people buying medicines from pharmacies for their own care and refraining from visiting the emergency department. In contrast, in Seine-Saint-Denis, which is a French department bordering Paris to the northeast and is a part of Greater Paris, Lapostolle et al. reported that the COVID-19 pandemic increased the number of calls for the Service d’Aide Medicale Urgente (SAMU) and the number of emergency department visits compared to the average of the previous five years [20]. The SAMU in France provides several medical services such as medical advice and hospital transfer by a non-emergency transport ambulance. Contrastingly, the only service provided by the EMS system in Japan is ambulance dispatch, and the differences in services provided by the SAMU in France versus the EMS system in Japan may have affected the difference in results. Further, Saberian et al. reported an increase in the number of EMS calls and ambulance dispatches after the first COVID-19 patient was identified on 18 February 2020 in Tehran, Iran [21]. The EMS system in Iran is similar to that in Japan in that the EMS personnel evaluate the patient at the scene and, if necessary, transport the patient to a hospital. The difference of results between the study in Japan and that in Iran, which operates a similar EMS system, may be due to the fact that Japanese people who used to call an ambulance even in cases not necessarily requiring an ambulance are now discouraged from visiting hospitals and clinics due to the risk of COVID-19.

The number of emergency patients due to sports injuries, industrial accidents, and traffic accidents also decreased in 2020 compared to 2019. In Japan, the Japanese government requested temporary closures of elementary, junior high, and high schools on 2 March 2020 [22], and the temporary closure of these schools continued until 31 May 2020 in Osaka Prefecture. In addition, many sports gyms have refrained from operating as a result of COVID-19 outbreaks in some of these gyms. As a result of this reduction in opportunities for sports in schools and gyms, the number of emergency patients due to sports injuries would likely have decreased. In Japan, although no explicit lockdown measures were taken by the government, the number of emergency patients due to traffic accidents and industrial accidents may have also decreased because of the slowdown in socioeconomic activity due to the voluntary restraint of various companies. Subgroup analyses by age group showed a decrease in patients transported by ambulance among children starting in January and a decrease in patients transported by ambulance among adults and the elderly after March. This result may be due to parents being less likely to visit the emergency department due to vigilance against an unknown infectious disease. In addition, as a result of school closures, they may not have visited emergency departments as a result of fewer cases of seasonal influenza in their children.

There was no change in the number of deaths of emergency patients admitted to hospital in 2020 compared with 2019. There were also no differences in the number of deaths of emergency patients admitted to hospital in the analyses by reason for ambulance call or by age group. Indeed, several previous studies have reported that COVID-19 outbreaks have reduced emergency patients due to influenza and mortality due to other infectious diseases [23,24]. On the other hand, there were concerns that other acute illnesses might affect the prognosis of emergency elderly patients due to an increase in demand for medical care. However, no impact on their prognosis was identified in this study because the health care system and EMS system functioned effectively for the community as a whole. To maintain the level of medical treatment in future surges of the COVID-19 pandemic and other infectious disease pandemics, it will be necessary to establish a medical and health care system with a clear role for medical institutions.

This study has several limitations. First, although all fire departments and emergency medical institutions in Osaka Prefecture registered ambulance records and patient data in the ORION registry, the prognosis of patients transported to medical institutions outside Osaka Prefecture or by fire departments outside Osaka Prefecture is unknown. Second, no information was available on the detailed treatment of the patients in hospital that would have affected death after hospital admission. Third, although this study was analysed by reason for ambulance call, a detailed analysis of the impact of the COVID-19 pandemic on the EMS system by disease, such as out-of-hospital cardiac arrest, acute coronary syndrome, and pneumonia, will be performed and reported in the near future. Fourth, as we included the emergency patients in this study, the impact of the COVID-19 pandemic on all causes of death in Osaka was unknown. Fifth, we did not include the deaths in the emergency department in this study. Many of the patients who died in the emergency department were the patients with out-of-hospital cardiopulmonary arrest. Prehospital factors such as bystander cardiopulmonary resuscitation can affect the outcomes of patients with out-of-hospital cardiopulmonary arrest. Therefore, we did not include these patients in this study.

5. Conclusions

In Osaka Prefecture, Japan, the incidence of emergency patients transported by ambulance decreased during the COVID-19 pandemic in 2020, but the mortality of emergency patients admitted to hospital did not change. The impact of the COVID-19 pandemic on the EMS system will need to be monitored over the long term.

Acknowledgments

We are deeply indebted to all of the Emergency Medical Service personnel and concerned physicians in Osaka Prefecture and to the Osaka Medical Association for their indispensable cooperation and support. This article was supported by the Osaka University Center of Medical Data Science and Advanced Clinical Epidemiology Investigator’s Research Project, which provided insight and expertise for our research.

Author Contributions

Conceptualization, all authors; methodology, Y.K. (Yusuke Katayama), K.T., T.K. and T.T.; software, K.T. and T.K.; validation, T.K. and T.T.; formal analysis, K.T. and T.T.; investigation, Y.K. (Yusuke Katayama); resources, all authors; data curation, all authors; writing—original draft preparation, Y.K. (Yusuke Katayama) and T.K.; writing—review and editing, all authors; visualization, K.T.; supervision, T.I. and T.S.; project administration, Y.K. (Yusuke Katayama); funding acquisition, Y.K. (Yusuke Katayama). All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Japan Society for the Promotion of Science KAKENHI (grant no. JP21K09071).

Institutional Review Board Statement

This study was approved by the Ethics Committee of Osaka University Graduate School of Medicine (approval no. 15003). In addition, this manuscript was written based on the STROBE statement to assess the reporting of cohort and cross-sectional studies. All methods in this study were carried out in accordance with the declaration of Helsinki.

Informed Consent Statement

ORION data are considered administrative records and the ORION data are anonymized without specific personal data, such as patient name, date of birth, and address. Therefore, the requirement of obtaining patient informed consent was waived.

Data Availability Statement

The data that support the findings of this study are available from the Osaka Prefectural government, but the availability of these data is restricted. Data cannot be shared publicly because of the Protection Ordinance for Personal Information in Osaka Prefecture. Data may be applied for if a qualified researcher applies for the data and the research is approved by the technical committee (http://www.pref.osaka.lg.jp/iryo/qq/orion_teikyo.html, (accessed on 1 November 2021), in Japanese).

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Ministry of Health, Labour and Welfare The Open Dataset of Patients with COVID-19. [(accessed on 16 June 2021)]; Available online: https://www.mhlw.go.jp/stf/covid-19/open-data.html. (In Japanese)
  • 2.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutiérrez-Ocampo E., Villamizar-Peña R., Holguin-Rivera Y., Escalera-Antezana J.P., Alvarado-Arnez L.E., Bonilla-Aldana D.K., Franco-Paredes C., Henao-Martinez A.F., et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Prezant D.J., Zeig-Owens R., Schwartz T., Liu Y., Hurwitz K., Beecher S., Weiden M.D. Medical Leave Associated With COVID-19 Among Emergency Medical System Responders and Firefighters in New York City. JAMA Netw. Open. 2020;3:e2016094. doi: 10.1001/jamanetworkopen.2020.16094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Katayama Y., Kitamura T., Kiyohara K., Iwami T., Kawamura T., Hayashida S., Yoshiya K., Ogura H., Shimazu T. Factors associated with the difficulty in hospital acceptance at the scene by emergency medical service personnel: A population-based study in Osaka City, Japan. BMJ Open. 2016;6:e013849. doi: 10.1136/bmjopen-2016-013849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Okamoto J., Katayama Y., Kitamura T., Sado J., Nakamura R., Kimura N., Misaki H., Yamao S., Nakao S., Nitta M., et al. Profile of the ORION (Osaka emergency information Research Intelligent Operation Network system) between 2015 and 2016 in Osaka, Japan: A population-based registry of emergency patients with both ambulance and in-hospital records. Acute Med. Surg. 2019;6:12–24. doi: 10.1002/ams2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Takeuchi T., Imanaka T., Katayama Y., Kitamura T., Sobue T., Shimazu T. Profile of patients with novel coronavirus disease 2019 (COVID-19) in Osaka Prefecture, Japan: A population-based descriptive study. J. Clin. Med. 2020;9:2925. doi: 10.3390/jcm9092925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ministry of Health, Labour and Welfare The Treatment Guidelines about COVID-19. [(accessed on 24 November 2020)]; Available online: https://www.mhlw.go.jp/content/000631552.pdf. (In Japanese)
  • 9.Osaka Prefectural Government The Open Data about COVID-19. [(accessed on 17 June 2021)]; Available online: https://covid19-osaka.info/ (In Japanese)
  • 10.Katayama Y., Kiyohara K., Kitamura T., Hayashida S., Shimazu T. Influence of the COVID-19 pandemic on an emergency medical service system: A population-based, descriptive study in Osaka, Japan. Acute Med. Surg. 2020;7:e534. doi: 10.1002/ams2.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Katayama Y., Kitamura T., Kiyohara K., Iwami T., Kawamura T., Izawa J., Gibo K., Komukai S., Hayashida S., Kiguchi T., et al. Improvements in Patient Acceptance by Hospitals Following the Introduction of a Smartphone App for the Emergency Medical Service System: A Population-Based Before-and-After Observational Study in Osaka City, Japan. JMIR mHealth uHealth. 2017;5:e134. doi: 10.2196/mhealth.8296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Osaka Prefectural Government Estimated Population of Osaka Prefecture in 2019. [(accessed on 17 June 2021)]; Available online: http://www.pref.osaka.lg.jp/attach/3387/00014731/R1nenpou.pdf. (In Japanese)
  • 13.von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370:1453–1457. doi: 10.1016/S0140-6736(07)61602-X. [DOI] [PubMed] [Google Scholar]
  • 14.Stella F., Alexopoulos C., Scquizzato T., Zorzi A. Impact of the COVID-19 outbreak on emergency medical system missions and emergency department visits in the Venice area. Eur. J. Emerg. Med. 2020;27:298–300. doi: 10.1097/MEJ.0000000000000724. [DOI] [PubMed] [Google Scholar]
  • 15.Man C.Y., Yeung R.S., Chung J.Y., Cameron P. Impact of SARS on an emergency department in Hong Kong. Emerg. Med. 2003;15:418–422. doi: 10.1046/j.1442-2026.2003.00495.x. [DOI] [PubMed] [Google Scholar]
  • 16.Ko P.C.-I. Emergency Medical Services Utilization during an Outbreak of Severe Acute Respiratory Syndrome (SARS) and the Incidence of SARS-associated Coronavirus Infection among Emergency Medical Technicians. Acad. Emerg. Med. 2004;11:903–911. doi: 10.1197/j.aem.2004.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tsai M.C., Arnold J.L., Chuang C.C., Chi C.H., Liu C.C., Yang Y.J. Impact of an outbreak of severe acute respiratory syndrome on a hospital in Taiwan, ROC. Emerg. Med. J. 2004;21:311–316. doi: 10.1136/emj.2003.011122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Huang C.-C., Yen D.H.-T., Huang H.-H., Kao W.-F., Wang L.-M., Huang C.-I., Lee C.-H. Impact of Severe Acute Respiratory Syndrome (SARS) Outbreaks on the Use of Emergency Department Medical Resources. J. Chin. Med. Assoc. 2005;68:254–259. doi: 10.1016/S1726-4901(09)70146-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Huang H.-H., Yen D.H.-T., Kao W.-F., Wang L.-M., Huang C.-I., Lee C.-H. Declining Emergency Department Visits and Costs during the Severe Acute Respiratory Syndrome (SARS) Outbreak. J. Formos. Med. Assoc. 2006;105:31–37. doi: 10.1016/S0929-6646(09)60106-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lapostolle F., Goix L., Vianu I., Chanzy E., De Stefano C., Gorlicki J., Petrovic T., Adnet F. COVID-19 epidemic in the Seine-Saint-Denis Department of Greater Paris: One month and three waves for a tsunami. Eur. J. Emerg. Med. 2020;27:274–278. doi: 10.1097/MEJ.0000000000000723. [DOI] [PubMed] [Google Scholar]
  • 21.Saberian P., Conovaloff J.L., Vahidi E., Hasani-Sharamin P., Kolivand P.-H. How the COVID-19 Epidemic Affected Prehospital Emergency Medical Services in Tehran, Iran. West. J. Emerg. Med. 2020;21:110–116. doi: 10.5811/westjem.2020.8.48679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Prime Minister’s Office of Japan The Minutes of 15th Headquarters Meeting on COVID-19. [(accessed on 17 June 2021)]; Available online: https://www.kantei.go.jp/jp/98_abe/actions/202002/27corona.html. (In Japanese)
  • 23.Hirose T., Katayama Y., Tanaka K., Kitamura T., Nakao S., Tachino J., Nakao S., Nitta M., Iwami T., Fujimi S., et al. Reduction of Influenza in Osaka, Japan During the COVID-19 Outbreak: A Population-based ORION Registry Study. IJID Reg. 2021;1:79–81. doi: 10.1016/j.ijregi.2021.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yorifuji T., Matsumoto N., Takao S. Excess All-Cause Mortality during the COVID-19 Outbreak in Japan. J. Epidemiol. 2021;31:90–92. doi: 10.2188/jea.JE20200492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the Osaka Prefectural government, but the availability of these data is restricted. Data cannot be shared publicly because of the Protection Ordinance for Personal Information in Osaka Prefecture. Data may be applied for if a qualified researcher applies for the data and the research is approved by the technical committee (http://www.pref.osaka.lg.jp/iryo/qq/orion_teikyo.html, (accessed on 1 November 2021), in Japanese).


Articles from Journal of Clinical Medicine are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES